UPDATE 1-Infection worries prompt regulatory reviews of Gilead leukaemia drug
 

UPDATE 1-Infection worries prompt regulatory reviews of Gilead leukaemia drug
LONDON, March 11 (Reuters) - European and U.S. regulatorsare reviewing the safety of Gilead Sciences' leukaemiadrug Zydelig due to concerns over serious adverse events,including deaths.http://feeds.feedburner.com/~ff/reut...?d=yIl2AUoC8zA http://feeds.feedburner.com/~ff/reut...Fg:V_sGLiPBpWU http://feeds.feedburner.com/~ff/reut...Fg:F7zBnMyn0Lo
http://feeds.feedburner.com/~r/reute...~4/bx6DJZs6I6Q